{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:39:43Z","timestamp":1770349183268,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Toxicol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11419-025-00714-7","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:53:23Z","timestamp":1740808403000},"page":"235-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eleven new metabolites of fluvoxamine detected in the solid tissues and body fluids obtained from a deceased overdosed with fluvoxamine in vivo, and the metabolites in the human liver microsomes in vitro using LC-HR\u2013MS\/MS"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1304-7783","authenticated-orcid":false,"given":"Kayoko","family":"Minakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Yuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koutaro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"714_CR1","first-page":"289","volume":"1","author":"J Irons","year":"2005","unstructured":"Irons J (2005) Fluvoxamine in the treatment of anxiety disorders. Neuropsychiatr Dis Treat 1:289\u2013299","journal-title":"Neuropsychiatr Dis Treat"},{"key":"714_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/00007691-199212000-00010","volume":"14","author":"MH de Vries","year":"1992","unstructured":"de Vries MH, Raghoebar M, Mathlener IS, van Harten J (1992) Single and multiple oral dose fluvoxamine kinetics in young and elderly subjects. Ther Drug Monit 14:493\u2013498","journal-title":"Ther Drug Monit"},{"key":"714_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF03188757","volume":"8","author":"H Overmars","year":"1983","unstructured":"Overmars H, Scherpenisse PM, Post LC (1983) Fluvoxamine maleate: metabolism in man. Eur J Drug Metab Pharmacokinet 8:269\u2013280. https:\/\/doi.org\/10.1007\/BF03188757","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"714_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/00000433-199903000-00019","volume":"20","author":"GW Kunsman","year":"1999","unstructured":"Kunsman GW, Rodriguez R, Rodriguez P (1999) Fluvoxamine distribution in postmortem cases. Am J Forensic Med Pathol 20:78\u201383. https:\/\/doi.org\/10.1097\/00000433-199903000-00019","journal-title":"Am J Forensic Med Pathol"},{"key":"714_CR5","doi-asserted-by":"publisher","first-page":"349S","DOI":"10.1111\/j.1365-2125.1983.tb02125.x","volume":"15","author":"V Claassen","year":"1983","unstructured":"Claassen V (1983) Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br J Clin Pharmac 15:349S-355S","journal-title":"Br J Clin Pharmac"},{"key":"714_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2116\/analsci.19.859","volume":"19","author":"T Ohkubo","year":"2003","unstructured":"Ohkubo T, Shimoyama R, Otani K, Yoshida K, Higuchi H, Shimizu T (2003) High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasma. Anal Sci 19:859\u2013864","journal-title":"Anal Sci"},{"key":"714_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00213-003-1430-1","volume":"167","author":"G Gerstenberg","year":"2003","unstructured":"Gerstenberg G, Aoshima T, Fukasawa T, Yoshida K, Takahashi H, Higuchi H, Murata Y, Shimoyama R, Ohkubo T, Shimizu T, Otani K (2003) Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients. Psychopharmacology 167:443\u2013448. https:\/\/doi.org\/10.1007\/s00213-003-1430-1","journal-title":"Psychopharmacology"},{"key":"714_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jpba.2004.09.037","volume":"37","author":"NY Furukori","year":"2005","unstructured":"Furukori NY, Inoue Y, Kaneko S, Otani K (2005) Determination of fluvoxamine and its metabolite fluvoxamino acid by liquid\u2013liquid extraction and column-switching high-performance liquid chromatography. J Pharm Biomed Anal 37:121\u2013125. https:\/\/doi.org\/10.1016\/j.jpba.2004.09.037","journal-title":"J Pharm Biomed Anal"},{"key":"714_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","volume":"24","author":"M Schulz","year":"2020","unstructured":"Schulz M, Schmoldt A, Andresen-Streichert H, Iversen-Bergmann S (2020) Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care 24:195. https:\/\/doi.org\/10.1186\/s13054-020-02915-5","journal-title":"Crit Care"},{"key":"714_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","volume":"165","author":"FT Peters","year":"2007","unstructured":"Peters FT, Drummer OH, Musshoff F (2007) Validation of new metabolites. Forensic Sci Int 165:216\u2013224","journal-title":"Forensic Sci Int"},{"key":"714_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/jat\/bkaa031","volume":"44","author":"K Minakata","year":"2020","unstructured":"Minakata K, Hasegawa K, Yamagishi I, Nozawa H, Suzuki M, Kitamoto T, Suzuki O, Watanabe K (2020) In vivo metabolites of AB-PINACA in solid tissues obtained from its abuser: comparison with in vitro experiment. J Anal Toxicol 44:1027\u20131035. https:\/\/doi.org\/10.1093\/jat\/bkaa031","journal-title":"J Anal Toxicol"},{"key":"714_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/jat\/bkaa120","volume":"45","author":"K Minakata","year":"2021","unstructured":"Minakata K, Hasegawa K, Nozawa H, Yamagishi I, Suzuki M, Kitamoto T, Suzuki O, Watanabe K (2021) Quantification of major metabolites of AB-FUBINACA in solid tissues obtained from an abuser. J Anal Toxicol 45:555\u2013565. https:\/\/doi.org\/10.1093\/jat\/bkaa120","journal-title":"J Anal Toxicol"},{"key":"714_CR13","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1016\/j.arabjc.2019.06.001","volume":"13","author":"A Naz","year":"2020","unstructured":"Naz A, Iqtadar R, Siddiqui FA, Ul-Haq Z (2020) Degradation kinetics of fluvoxamine in buffer solutions: in silico ADMET profiling and identification of degradation products by LC\u2013MS\/ESI. Arab J Chem 13:4131\u20134146. https:\/\/doi.org\/10.1016\/j.arabjc.2019.06.001","journal-title":"Arab J Chem"},{"key":"714_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/hep.26208","volume":"58","author":"M Chen","year":"2013","unstructured":"Chen M, Borlak J, Tong W (2013) High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology 58:388\u2013396. https:\/\/doi.org\/10.1002\/hep.26208","journal-title":"Hepatology"},{"key":"714_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/030006059302100405","volume":"21","author":"R Garnier","year":"1993","unstructured":"Garnier R, Azoyan P, Chataigner D, Taboulet P, Dellattre D, Efthymiou ML (1993) Acute fluvoxamine poisoning. J Int Med Res 21:197\u2013208","journal-title":"J Int Med Res"},{"key":"714_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/15563650701664574","volume":"45","author":"DM Wood","year":"2007","unstructured":"Wood DM, Rajalingam Y, Greene SL, Morgan PE, Gerrie D, Jones AL, Dargan PI (2007) Status epilepticus following intentional overdose of fluvoxamine: a case report with serum fluvoxamine concentration. Clin Toxicol 45:791\u2013793. https:\/\/doi.org\/10.1080\/15563650701664574","journal-title":"Clin Toxicol"},{"key":"714_CR17","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.forsciint.2019.02.047","volume":"300","author":"J Otter","year":"2019","unstructured":"Otter J, McIntyre IM, Morhaime J, Cantrell L (2019) A fluvoxamine-related fatality: case report with postmortem concentrations. Forensic Sci Int 300:e31\u2013e33. https:\/\/doi.org\/10.1016\/j.forsciint.2019.02.047","journal-title":"Forensic Sci Int"},{"key":"714_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s44192-023-00036-3","volume":"3","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K (2023) Overview of the potential use of fluvoxamine for COVID-19 and long COVID. Discover Mental Health 3:9. https:\/\/doi.org\/10.1007\/s44192-023-00036-3","journal-title":"Discover Mental Health"},{"key":"714_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2501","author":"J Deng","year":"2024","unstructured":"Deng J, Moskalyk M, Zuo QK, Garcia C, Abbas U, Ramaraju HB, Rayner D, Park YJ, Heybati K, Zhou F, Lohit S (2024) Evaluating fluvoxamine for the outpatient treatment of COVID-19: a systematic review and meta-analysis. Rev Med Virol. https:\/\/doi.org\/10.1002\/rmv.2501","journal-title":"Rev Med Virol"},{"issue":"5","key":"714_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300512","volume":"19","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Zhao G, Pan Y, Zhang Y, Ni Y (2024) The efficacy and safety of fluvoxamine in patients with COVID-19: a systematic review and meta-analysis from randomized controlled trials. PLoS ONE 19(5):e0300512. https:\/\/doi.org\/10.1371\/journal.pone.0300512","journal-title":"PLoS ONE"}],"container-title":["Forensic Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-025-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11419-025-00714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-025-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:44:34Z","timestamp":1752137074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11419-025-00714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1007\/s11419-025-00714-7","relation":{},"ISSN":["1860-8965","1860-8973"],"issn-type":[{"value":"1860-8965","type":"print"},{"value":"1860-8973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The analysis of toxic substances from a cadaver was permitted by judicial authorities and supported by official documentation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}